EGFR and nasopharyngeal carcinoma: In addition, Liu and colleagues established a method named PLA‐RPA‐TMA assay: two proximity ligation assay (PLA) probes recognize biomarkers such as LMP or EGFR protein on tumor‐derived EVs in NPC, and then generate the unique surrogate DNA signal for these biomarkers.